In the present study, we comprehensively analyzed the expression and prognostic value of PSMD1 and PSMD3 across multiple cancer types using data from The Cancer Genome Atlas (TCGA) [33] and the Clinical Proteomic Tumor Analysis Consortium (CPTAC) [34,35], comparing expression with OS. Here, PSMD3 is linked to neoplasm.